By: Spencer Sherman, Pharm.D., Clinical Pharmacist, Enlyte Pharmacy Solutions On December 19, 2023, the U.S. Food and Drug Administration (FDA) approved the first test (AvertD) that uses DNA in assessing whether certain individuals may have an elevated […]

Author: Spencer Sherman, Pharm.D., Clinical Pharmacist, Enlyte Opioids continue to represent a decreasing portion of overall workers’ compensation prescriptions, with favorable trends being seen in markers such as dose and duration of use. Despite declines, […]